Source: Eur Respir J, 50 (4) 1700521; 10.1183/13993003.00521-2017



Rating:

Share or cite this content

Citations should be made in the following way:
Li Zhang, Gustavo Pacheco-Rodriguez, Wendy K. Steagall, Jiro Kato, Thomas V. Colby, Mary Haughey, Joel Moss. BRAF and NRAS mutations in circulating Langerhans-like CD1a⁺ cells in a patient with pulmonary Langerhans’ cell histiocytosis. Eur Respir J, 50 (4) 1700521; 10.1183/13993003.00521-2017

Member's Comments

No comment yet.

Related content which might interest you: Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis Source: Eur Respir J 2016; 47:1785-1796 Year: 2016 Clinical impact of BRAFV600E mutation in adult pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Towards a better understanding of rare diffuse parenchymal lung diseases Year: 2019 Chemotherapy in patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Genetic landscape of adult Langerhans cell histiocytosis with lung involvement Source: Eur Respir J, 55 (2) 1901190; 10.1183/13993003.01190-2019 Year: 2020 The use of immunohistochemical stains to identify Langerhans cells in pulmonary histiocytosis Source: International Congress 2015 – Systemic and airway biomarkers Year: 2015 Pulmonary Langerhans' cell histiocytosis Source: Respipedia Article Year: 2016 How I manage pulmonary Langerhans cell histiocytosis Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017 Year: 2017 Langerhans cell histiocytosis: is it an ILD? Source: Virtual Congress 2021 – Interstitial lung diseases Year: 2021 Lung function progression in Langerhans cell histiocytosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Lack of evidence for the involvement of Merkel cell polyomavirus in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 6 (2) 00230-2019; 10.1183/23120541.00230-2019 Year: 2020 Pneumothorax in patients with Langerhans cell histiocytosis Source: International Congress 2017 – The acute patient: the clinical point-of-view Year: 2017 Pulmonary Langerhans cell histiocytosis Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases Year: 2008 Pulmonary Langerhans‘ cell histiocytosis Source: Eur Respir J 2006; 28: Suppl. 50, 826s Year: 2006 Adult pulmonary Langerhans' cell histiocytosis Source: Eur Respir J 2006; 27: 1272-1285 Year: 2006 Genetic landscape of pulmonary langerhans cell histiocytosis Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018 Effect of cladribine therapy on lung cysts in pulmonary Langerhans cell histiocytosis Source: ERJ Open Res, 4 (1) 00089-2017; 10.1183/23120541.00089-2017 Year: 2018 A role for ITPA variants in the clinical course of pulmonary Langerhans' cell histiocytosis? Source: Eur Respir J 2010; 36: 684-686 Year: 2010 Clinical features and outcome of adult patients with pulmonary Langerhans cell histiocytosis Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Pulmonary Langerhans' cell histiocytosis Source: Eur Respir Mon; 2009: 46: 155–175 Year: 2009